VAN WIJMEERSCH, Bart

Email Alert RSS Feed

Profile

Full Name
VAN WIJMEERSCH, Bart
Email
bart.vanwijmeersch@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 161-180 of 208 (Search time: 0.001 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1612017Teri-DYNAMIC: Exploring the impact of teriflunomide on immune cell population size, receptor repertoire, and function in patients with RRMSWiendl, Heinz; Gross, Catharina C.; Eschborn, Melanie; Weisser, Linda; Posevitz-Fejfar, Anita; Schulte-Mecklenbeck, Andreas; VAN WIJMEERSCH, Bart; Hupperts, Raymond; Brette, Sandrine; Turner, Timothy J.; Bar-Or, Amit; Klotz, LuisaJournal ContributionM
1622017Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation studyCosters, Lars; Gielen, Jeroen; Eelen, Piet L.; van Schependom, Jeroen; Laton, Jorne; Van Remoortel, Ann; VANZEIR, Ellen; VAN WIJMEERSCH, Bart; Seeldrayers, Pierrette; Haelewyck, Marie-Claire; D'Haeseleer, Miguel; D'hooghe, Marie-Beatrice; Langdon, Dawn; Nagels, GuyJournal ContributionA1
1632016B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responsesFRAUSSEN, Judith; CLAES, Nele; VAN WIJMEERSCH, Bart; VAN HORSSEN, Jack; STINISSEN, Piet; Hupperts, Raymond; SOMERS, VeerleJournal ContributionA1
1642016Effects of an individual 12 weeks community located running program on physical capacity, walking, cognitive function, dual tasking and brain volumes and structures in persons with Multiple Sclerosis.FEYS, Peter; MOUMDJIAN, Lousin; Vanhalewyck, F.; WENS, Inez; OP 'T EIJNDE, Bert; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Dufour, A.; Delva, S.; VAN ASCH, PaulJournal ContributionM
1652016Effects of teriflunomide treatment on the CD4(+) T-cell receptor repertoire in patients with relapsing-remitting MSKlotz, Luisa; Lindner, Maren; Gross, Catherina C.; Eschborn, Melanie; Posevitz-Fejfar, Anita; Schulte-Mecklenbeck, Andreas; Meuth, S. G.; VAN WIJMEERSCH, Bart; Hupperts, Raymond; Maeurer, M.; Stangel, M.; Lang, M.; Tackenberg, B.; Lysandropoulos, A.; Decoo, D.; Eveslage, M.; Turner, Timothy J.; Jagerschmidt, A.; Bar-Or, Amit; Wiendl, HeinzJournal ContributionM
1662016Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatmentBermel, R.; Comi, G.; Eralinna, J. -P.; Leist, T. P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Bernasconi, C.; Buffels, R.; Csoboth, C.; Han, J.; Musch, B.; Vermersch, P.Journal ContributionM
1672016Brain atrophy by automated MRI reading in long-term natalizumab treated patients: Real world data suggests brain atrophy rates in range of healthy individualsHorakova, Dana; Uher, T.; Vaneckova, M.; Krasensky, J.; Seidl, Z.; van Pesch, V.; Lysandropoulos, A.; VAN WIJMEERSCH, Bart; Ribbens, A.; van Hecke, W.; Dong, Q.; Farkas, M.; Hyde, R.; Koendgen, H.Journal ContributionM
1682016Durable improvement in clinical outcomes in treatmentnaive patients with relapsing-remitting multiple sclerosis who switched from SC IFNB-1a to alemtuzumab (care-MS I extension study 4-year follow-up)Oreja-Guevara, C.; Alroughani, R.; Brassat, D.; Boyko, A. N.; McCombe, P.; Steingo, B.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Vermersch, P.Journal ContributionM
1692016Upper Limb Rehabilitation in People With Multiple Sclerosis: A Systematic ReviewLAMERS, Ilse; MARIS, Anneleen; SEVERIJNS, Deborah; Dielkens, Wouter; Geurts, Sander; VAN WIJMEERSCH, Bart; FEYS, PeterJournal ContributionA1
1702016Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I).Coles, A. J.; Boyko, A. N.; Cohen, J. A.; De Seze, J.; Fox, E. J.; Havrdova, E.; Hartung, H. -P.; Inshasi, J. S.; McCombe, P.; Selmaj, K. W.; Vermersch, P.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Montalban, X.Journal ContributionM
1712016Durable reduction in MRI disease activity with alemtuzumab in treatment-naive patients with active relapsing-remitting multiple sclerosis: 6-year follow-up of the CARE-MS I studyArnold, D. L.; Barnett, M.; Comi, G.; Giovannoni, G.; Pelletier, D.; Rovira, A.; Schippling, S.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Traboulsee, A.Journal ContributionM
1722016Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis PatientsCLAES, Nele; FRAUSSEN, Judith; VANHEUSDEN, Marjan; HELLINGS, Niels; STINISSEN, Piet; VAN WIJMEERSCH, Bart; Hupperts, Raymond; SOMERS, VeerleJournal ContributionA1
1732015Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosisJANSSENS, Kris; Van den Haute, C.; Baekelandt, Veerle; Lucas, S.; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HELLINGS, Niels; HENDRIKS, Jerome; SLAETS, Leen; SOMERS, VeerleJournal ContributionA1
1742015Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression indexDE BOCK, Laura; FRAUSSEN, Judith; Villar, Luisa M.; Alvarez-Cermeno, Jose C.; VAN WIJMEERSCH, Bart; van Pesch, Vincent; STINISSEN, Piet; SOMERS, VeerleJournal ContributionA1
1752015Characterizing the impact of teriflunomide on adaptive immune cell subsets, repertoire and function in patients with relapsing-remitting MS: TERI-DYNAMICWiendl, H.; Gross, C. C.; Lindner, M.; Eschborn, M.; Weisser, L.; Posevitz-Fejfar, A.; Schulte-Mecklenbeck, A.; VAN WIJMEERSCH, Bart; Hupperts, R.; Lunven, C.; Brette, S.; Turner, T. J.; Klotz, L.Journal ContributionM
1762015B cells from MS patients induce autoreactive Th1 and Th17 responsesFRAUSSEN, Judith; CLAES, Nele; HELLINGS, Niels; VAN WIJMEERSCH, Bart; STINISSEN, Piet; Hupperts, R.; SOMERS, VeerleJournal ContributionM
1772015Optimizing therapy early in multiple sclerosis: An evidence-based viewZiemssen, Tjalf; De Stefano, Nicola; Sormani, Maria Pia; VAN WIJMEERSCH, Bart; Wiendl, Heinz; Kieseier, Bernd C.Journal ContributionA1
1782015IL-15 Amplifies the Pathogenic Properties of CD4+CD28- T Cells in Multiple SclerosisBROUX, Bieke; Mizee, Mark R.; VANHEUSDEN, Marjan; VAN DER POL, Susanne; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; SOMERS, Veerle; DE VRIES, Helga E.; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
1792015Overview of the management of relapsing-remitting multiple sclerosis and practical recommendationsGallo, P.; VAN WIJMEERSCH, BartJournal ContributionA1
1802015Associations of Upper Limb Disability Measures on Different Levels of the International Classification of Functioning, Disability and Health in People With Multiple SclerosisLAMERS, Ilse; Cattaneo, Davide; Chen, Christine C.; Bertoni, Rita; VAN WIJMEERSCH, Bart; FEYS, PeterJournal ContributionA1
show all